Journal: Vaccines
Article Title: Toward a SARS-CoV-2 VLP Vaccine: HBc/G as a Carrier for SARS-CoV-2 Spike RBM and Nucleocapsid Protein-Derived Peptides
doi: 10.3390/vaccines12030267
Figure Lengend Snippet: Target fusion genes and general scheme of the pET-28a(+)-based expression vector for the expression of HBc/G-SARS-CoV-2 fusion proteins. ( A ) NcoI/BamHI fragments used in the cloning (blue boxes represent the partial or full sequence of the HBc/G gene, numerals indicate the length of the HBc/G protein, the RBM fragment is shown in green, the B-cell epitope containing peptide of the N protein is shown in yellow, and the string of five CTL epitopes from the N protein is shown in red. The names of the corresponding expression plasmids are given on the right side. ( B ) General scheme of the pET-28a(+)-based expression vector. Kanamycin resistance gene is shown in orange, HBc/G is shown in blue; inserts: RBM in green, Bep in yellow, CTL string in red.
Article Snippet: E. coli expression vectors based on the pET-28a(+) plasmid with the appropriate HBc/G fusion protein gene ( ) were commercially obtained from BioCat GmbH (Heidelberg, Germany).
Techniques: Expressing, Plasmid Preparation, Cloning, Sequencing